Neurotech International Limited (ASX: NTI)
Sector: Health Care
Market cap: A$27M (as of 2 Nov 2026)
A clinical-stage biopharmaceutical development company focused on paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 19 Oct 2026 | Daniel Canu | Entry | — | Filing ↗ |
| 13 Aug 2026 | Merchant Funds Management Pty Ltd (ABN 32 154 493 277) as manager of the Merchant Opportunities Fund (ARSN 111 456 387) & Merchant Group Pty Ltd (ABN 56 154 832 237) & Merchant Funds Management and BSLH Pty Ltd 612 832 372 | Entry | ?% → 7.38% | Filing ↗ |
| 23 Apr 2026 | MAYBANK SECURITIES PTE. LTD. | Exit | ?% → 4.520% | Filing ↗ |
| 16 Oct 2025 | Biotech Capital Management Pty Ltd as investment manager of the Merchant Biotech Fund and related entities | Entry | ?% → 5.4% | Filing ↗ |
| 9 July 2025 | MAYBANK SECURITIES PTE. LTD. | Entry | ?% → 5.78% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 2 Oct 2026 | Mr Andrew David Chapman | Bought 7,900,000 | Filing ↗ |
| 3 Dec 2024 | Mr. Robert Maxwell Johnston | Bought 200,000 Fully Paid Ordinary Shares | Filing ↗ |
| 29 Jan 2024 | Dr Thomas George Duthy | Bought 340,000 NTI Ordinary Shares | Filing ↗ |
| 2 Aug 2022 | Mr Gerald Joseph Quigley | Bought 277,777 | Filing ↗ |
| 14 July 2021 | ALLAN WILLIAM CRIPPS | Bought 180,000 | Filing ↗ |
Cash and runway
Ask about NTI in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has NTI raised money in the last year, and at what discount?
- What was NTI's latest cash position and runway?
Loading NTI…